JANE STREET GROUP, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$4,353,000
-40.7%
63,922
-72.2%
0.00%
-33.3%
Q2 2022$7,344,000
-61.6%
229,859
-58.4%
0.00%
-50.0%
Q1 2022$19,129,000
+116.0%
552,192
+82.5%
0.01%
+100.0%
Q4 2021$8,855,000
+71.6%
302,519
+49.4%
0.00%0.0%
Q3 2021$5,160,000
-2.0%
202,527
+34.7%
0.00%0.0%
Q2 2021$5,263,000
-6.2%
150,314
+9.2%
0.00%0.0%
Q1 2021$5,610,000
-62.7%
137,653
-60.4%
0.00%
-57.1%
Q4 2020$15,046,000
+234.0%
347,431
+325.3%
0.01%
+133.3%
Q3 2020$4,505,000
-68.8%
81,696
-64.3%
0.00%
-72.7%
Q2 2020$14,454,000
+350.6%
228,942
+264.6%
0.01%
+175.0%
Q1 2020$3,208,000
-72.1%
62,800
-56.6%
0.00%
-75.0%
Q4 2019$11,495,000
+983.4%
144,605
+561.4%
0.02%
+700.0%
Q3 2019$1,061,000
-73.4%
21,862
-71.2%
0.00%
-66.7%
Q2 2019$3,994,000
+530.0%
75,942
+534.5%
0.01%
+500.0%
Q1 2019$634,000
-43.7%
11,969
-56.4%
0.00%
-66.7%
Q4 2018$1,127,000
+326.9%
27,458
+294.7%
0.00%
+200.0%
Q3 2018$264,000
-90.8%
6,956
-89.0%
0.00%
-85.7%
Q2 2018$2,864,000
+236.5%
63,376
+259.6%
0.01%
+250.0%
Q1 2018$851,000
+13.3%
17,622
-7.7%
0.00%0.0%
Q4 2017$751,000
+275.5%
19,090
+196.1%
0.00%
+100.0%
Q3 2017$200,000
-38.3%
6,447
-26.6%
0.00%0.0%
Q1 2017$324,000
-61.0%
8,780
-65.8%
0.00%
-80.0%
Q4 2015$830,00025,6790.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders